Aspire BioPharma Inc. (ASBP)
NASDAQ: ASBP
· Real-Time Price · USD
0.37
-0.05 (-12.74%)
At close: May 01, 2025, 3:59 PM
0.38
3.29%
After-hours: May 01, 2025, 07:51 PM EDT
-12.74% (1D)
| Bid | 0.32 |
| Market Cap | 17.99M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -12.47M |
| EPS (ttm) | -0.27 |
| PE Ratio (ttm) | -1.36 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.4 |
| Volume | 554,050 |
| Avg. Volume (20D) | 509,463 |
| Open | 0.45 |
| Previous Close | 0.42 |
| Day's Range | 0.33 - 0.45 |
| 52-Week Range | 0.33 - 15.80 |
| Beta | 0.86 |
About ASBP
Aspire BioPharma, Inc. is a biotechnology company specializing in advanced diagnostic solutions and molecular testing. The company focuses on developing high-precision assays for disease detection, leveraging cutting-edge research in genetics and biochemistry to support healthcare and life sciences industries....
Industry Biotechnology
Sector Healthcare
IPO Date Apr 11, 2022
Employees 2
Stock Exchange NASDAQ
Ticker Symbol ASBP
Website https://aspirebiolabs.com/
